The estimated Net Worth of Mark Doak is at least $21.9 Million dollars as of 3 March 2020. Mark Doak owns over 3,494 units of Agilent Technologies stock worth over $18,818,539 and over the last 10 years Mark sold A stock worth over $3,128,600.
Mark has made over 17 trades of the Agilent Technologies stock since 2014, according to the Form 4 filled with the SEC. Most recently Mark sold 3,494 units of A stock worth $292,832 on 3 March 2020.
The largest trade Mark's ever made was exercising 21,851 units of Agilent Technologies stock on 30 May 2017 worth over $875,570. On average, Mark trades about 5,051 units every 60 days since 2014. As of 3 March 2020 Mark still owns at least 135,678 units of Agilent Technologies stock.
You can see the complete history of Mark Doak stock trades at the bottom of the page.
Mark's mailing address filed with the SEC is 5301 STEVENS CREEK BLVD, , SANTA CLARA, CA, 95051.
Over the last 22 years, insiders at Agilent Technologies have traded over $170,735,833 worth of Agilent Technologies stock and bought 25,786 units worth $823,096 . The most active insiders traders include William P Sullivan, George A Scangos, and Mikael Dolsten. On average, Agilent Technologies executives and independent directors trade stock every 20 days with the average trade being worth of $3,748,368. The most recent stock trade was executed by Padraig Mcdonnell on 22 August 2024, trading 1,958 units of A stock currently worth $283,910.
analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.
Agilent Technologies executives and other stock owners filed with the SEC include: